Benoît Brethon

Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

Arend von Stackelberg, Franco Locatelli, Gerhard Zugmaier et al. · Journal of Clinical Oncology · 2016 · 605 citations · Full text

Medicine, Hematology, Oncology +17

Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome–positive leukemia

Kimmo Porkka, Perttu Koskenvesa, Tuija Lundán et al. · Blood · 2008 · 443 citations · Full text

Medicine, Hematology, Oncology +13

Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)

Nicolas Boissel, Harmony Leroy, Benoît Brethon et al. · Leukemia · 2006 · 355 citations

Medicine, Genetics, Oncology +14

Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study

Rob Pieters, Paola De Lorenzo, Philip Ancliffe et al. · Journal of Clinical Oncology · 2019 · 299 citations · Full text

Medicine, Hematology, Oncology +17

Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia

Inge M. van der Sluis, Paola De Lorenzo, Rishi S. Kotecha et al. · New England Journal of Medicine · 2023 · 204 citations

Medicine, Oncology, Pharmacology +17